newdrugapprovals.org
Sun Pharma, Merck & Co Inc ink pact for Tildrakizumab
Sep 17, 2014, Under terms of the agreement, Sun Pharma will acquire worldwide rights to tildrakizumab for use in all human indications from Merck in exchange for an upfront payment of USD 80…